benefits
NICE rejects ‘benefit’ test
January 28, 2014Sales and Marketing Dillon, EMIG, NHS, NICE, benefits
NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
